dr. Arjan van Laarhoven

Over Arjan van Laarhoven

We have therefore initiated the Radboud Mycobacterial Cohort Study (‘MyCoS’, CMO NL2021-13231) to systematically collect clinical, microbiological and immunological data of our patients, to eventually improve their care. I lead a substudy re-employing the tuberculin skin test as an in-vivo model for antimycobacterial immunity (MyCoS-TST, together with dr. Gabriele Pollara, UCL) and a substudy on skin and soft tissue infections (MyCoS-SSTI). Internationally, I participate as a postdoctoral researcher in two NIH-funded projects on tuberculous meningitis, aimed at metabolomics (‘ULTIMATE’) and proteomics (‘INTERCEPT’) to understand the immunopathophysiology and design targeted treatment. My PhD thesis "Host response in relation to tuberculosis susceptibility is available" at http://hdl.handle.net/2066/190507. More on MyCoS-SSTI: https://www.radboudumc.nl/en/news-1/2023/site-of-disease-immunological-and-pharmacological-research-on-complex-mycobacterial-skin-infections

Onder­scheidingen

• LEO foundation grant for research on non-tuberculous mycobacterial skin infections (2023-2026)
• ZonMw Clinical Fellowship 2023-2027
• Robert Sauerwein medaille 2022
• Radboud Center for Infectious Diseases starting grant 2021